Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 5:03 pm Purchase | 2026-06-30 | 13G | AVALYN PHARMA INC AVLN | Novo Holdings A/S | 3,883,289 8.800% | 3,883,289 (New Position) | Filing History |
| 2026-08-11 5:03 pm Purchase | 2026-06-30 | 13G | AVALYN PHARMA INC AVLN | Norwest Venture Partners XV, LP | 2,268,404 5.100% | 2,268,404 (New Position) | Filing History |
| 2026-08-06 10:59 am Purchase | 2026-06-30 | 13G | AVALYN PHARMA INC AVLN | FMR LLC | 5,835,259 13.200% | 1,042,951 (+21.76%) | Filing History |
| 2026-05-08 6:52 pm Purchase | 2026-05-01 | 13D | AVALYN PHARMA INC AVLN | Montanova Capital, LLC | 2,503,109 5.600% | 2,503,109 (New Position) | Filing History |
| 2026-05-08 4:41 pm Purchase | 2026-05-01 | 13D | AVALYN PHARMA INC AVLN | SR One Capital Management, LLC | 3,308,649 7.500% | 3,308,649 (New Position) | Filing History |
| 2026-05-07 4:16 pm Purchase | 2026-04-30 | 13G | AVALYN PHARMA INC AVLN | Perceptive Advisors LLC | 2,675,296 6.000% | 2,675,296 (New Position) | Filing History |
| 2026-05-05 10:06 am Purchase | 2026-05-01 | 13G | AVALYN PHARMA INC AVLN | FMR LLC | 4,792,308 11.500% | 4,792,308 (New Position) | Filing History |